Company profile
Annual Report 2013
LEI
cee stock exchange group
Issuers / Issuers News
Article print

13 Sep 2013 14:15 
Extraordinary Information
Marketing authorisation for biosimilar infliximab in EU
Attached documents:
Releaser: EGIS Pharmaceuticals PLC
Date Issued: 13 Sep 2013
 
Actual
2014 average
Name
Price
%
Turn. (tEUR)
-
800
0.00
0
-
191
0.00
0
-
401
0.00
0
-
229
0.00
0
-
5,100
0.00
0
-
808
0.00
0
-
12,100
0.00
0
-
360
0.00
0
-
4,154
0.00
0
-
345
0.00
0
-
1,209
0.00
0
-
3,919
0.00
0
-
149
0.00
0
-
4,288
0.00
0
Change %: to baseprice
Data delayed by 15 minutes
Indices
Index
Value
Change %
BUX
17,959.39
74.69 (0.42)
1,519.74
28.37 (1.90)
1,133.16
-6.67 (-0.59)
1,121.38
-5.77 (-0.51)
1,843.59
-16.29 (-0.88)